Cell lines, animal models, and genetic studies reveal the role of PCSK9 in several CNS diseases including Alzheimer’s disease, alcohol use disorder, ischemic stroke, and neuropsychiatric disorders. This evidence concerns the gene PCSK9 and early-onset autosomal dominant Alzheimer disease.